Targeted Drug Delivery, Not Just ADCs. How Far Are We from the “Magic Bullet”?
Date: January 20, 2016 @ 9:30 am – @ 9:30 am
Location: Embassy Suites, 250 Gateway Blvd., South San Francisco, CA 94080
CABS Science Workshop: Targeted Drug Delivery, Not Just ADCs. How Far Are We from the “Magic Bullet”?
As drug researchers, we were often excited about the “great” drug candidates and “great” drug targets we discovered, but only found out later that side effects (off-target toxicity) could not be practically handled, or the concern was too big. We wished if only we could deliver the drug to some site, or avoid some area. ADC (antibody drug conjugates) has generated exciting news, which is only a small part of targeted drug delivery. This workshop will present not only the advancement in ADC, but also other exciting progress and benefits of drug delivery to drug discovery and development.
Agenda:
| 9:30 - 10:00 AM | Registration, Coffee and Networking |
| 10:00 - 10:10 AM | Opening remarks and introduction |
| 10:10 - 11:00 AM | The Marriage of Nanomedicines with Cell Therapies; a Practical Approach or a Means to Keep Academic Drug Delivery Scientists Gainfully Employed? |
| Francis C. Szoka, Ph.D., Professor of Bioengineering, Therapeutic Science & Pharmaceutical Chemistry at the University of California School of Pharmacy in San Francisco | |
| 11:00 - 11:45 AM | Chemically Modified Viral Capsids as Versatile Nanoscale Delivery Agents |
| Matthew B. Francis, Ph.D., Professor of Chemistry, University of California, Berkeley, and Materials Sciences Division, Lawrence Berkeley National Laboratory | |
| 11:45 AM - 1:00 PM | Lunch & Networking |
| 1:00 - 1:45 PM | A New Biocompatible Condensation Reaction and Its Application for Molecular Imaging and Drug Delivery |
| Jianghong Rao, Ph.D., Associate Professor of Radiology and Chemistry (courtesy), as well as a member of the Molecular Imaging, Bio-X, Cancer Biology, and Biophysics Programs at Stanford University School of Medicine | |
| 1:45 - 2:30 PM | XTEN™ - Protein Polymer as a Drug Delivery Platform |
| Vladimir N. Podust, Ph.D., Director of Analytical Chemistry, Amunix Operating Inc. | |
| 2:30 - 3:15 PM | Stable and Efficacious Site Specific ADCs of Un-modified Antibodies Made Easy by Engineered Transglutaminase |
| Sean Hu, Ph.D., Senior Vice President, Dophen BioMed, Inc. | |
| 3:15 - 4:30 PM | Closing remarks & Networking |
* Lunch will be provided.
Registration Requirement:
Online registration is strongly encouraged.
Online: $25 for CABS members, $35 for non-members
Onsite: $45
.